Momentum Trades

MomentumOptionsTrading.com Weekly Wrap for 7/15/12

11:30pm (EST)

 

1.  Market Summary 

2.  Antares Pharmaceuticals (ATRS) – Possible Buyout?

3.  Homeowners Choice (HCII) – A Closer Look at the Recent IPO           

4.  Earnings

5.  Weekly Wrap Portfolio Update 

6.  Week Ahead

 

(To view the charts, please log into the Members Area and go to the Weekly Wrap Premium section)

 

= = = = = = = = = = = = = = =  

 

1.  Market Summary   

“The bulls were on the verge of a breakout last week and we often mention how support and resistance can get “stretched”.  Coming into June, the bears had all the momentum following May’s selloff and while we thought there could be further weakness, we knew the indexes were due for a bounce, or back test.  The rebound lasted a week longer than we anticipated due to the huge rally following the European Union (EU) summit but we knew their latest “plan” was just another excuse for kicking of the can down the road further.

There was a lot of bullishness going into Friday’s jobs data but just like we saw the bears have trouble cracking support, the bulls ran out of ammo when the number disappointed. 

We have mentioned the 2-month trading range the market has been in and Friday’s selloff was just one day.  This week will be all about the start of earnings and the FOMC minutes.

This earnings cycle could be one of the worst since 2009 as we have seen over 100 companies warn and lower estimates. Profits could fall nearly 2%, on average, according to the suit-and-ties.” (from 7/8/2012 Weekly Wrap/ Monday Morning Outlook)…

The bears were making a nasty assault on the bulls for much of the week after cracking major support levels following a mixed bag of earnings and continued worries over Europe.  The major indexes were dancing near their 100-day MA’s (moving averages) coming into the week and the 4-day selloff had pushed them below their 50-day MA’s by Thursday.  The 200-day MA’s were right in sight but Friday’s huge bounce gave the bulls a piece of the weekly win pie. 

Friday’s rally was all about JPMorgan Chase (JPM, $36.07, up $1.96) which beat Wall Street’s estimates and short-covering.  Shares rallied 6% on the news and closed just above their 50-day and 200-day MA’s.  The earnings bar was already lowered significantly for the company and they reported a wider-than-expected loss for its now famous “Whale trade”.  However, the company still made a profit which sent shares soaring.  

JP also lowered their guidance for the current quarter and in a perfect bears’ world, all of the negatives should have sent shares reeling.  The total loss for the London debacle is now estimated at $5.8 billion but no one knows what to believe.  There was a review of nearly 1 million emails and thousands and thousands of voice tapes that suggest a cover-up but we will let the market make those judgments. 

Going into Friday, the Dow and S&P 500 were down 2.2% for the week but both finished with slight gains.  The Nasdaq was down 94 points, or 3.4% for the week, before recovering most of its losses back off Thursday’s low.  The index still finished lower for the week along with the small-caps (Russell 2000).

We have mentioned volatility would be picking up and last week’s 2% intraday moves are a telling sign this market is ready to explode higher, or, Friday’s back test was the last in what could be a huge correction coming.      

The Dow zoomed 204 points, or 1.6%, to finish at 12,777 on Friday.  The blue-chips dipped to 12,606 on Tuesday and we highlighted the next level of support was at 12,600.  We said if this level failed to hold, the bears would target 12,400-12,350 and the 200-day MA.  Thursday’s low was 12,492 before the Dow rebounded to close at 12,573 and Friday’s rally gets 12,800-13,000 back into play over the near-term.  The Dow was at 12,772 going into Monday’s open and advanced 5 points, or 0.04%, for the week.  For 2012, the blue-chips are up 560 points, or 4.6%.

Here is last week’s chart.  We got a perfect test to the bottom channel before the bounce:

The S&P 500 soared 22 points, or 1.7%, to settle at 1,356.78.  The index traded down to 1,346 on Monday but was able to close above the 1,350 level which has been a key battle ground in recent weeks.  We had a good feeling support wouldn’t hold coming into the week and Tuesday’s close of 1,341 and the test to the 50-day MA opened the door for continued weakness to 1,325-1,300.  On Wednesday, we specifically said to watch for a close below 1,335 which would lead to 1,325.  The S&P traded to a low of 1,325.41 and closed at 1334.76 on Thursday.  Resistance again is at 1,375-1,400 going into the week.  The S&P 500 started the week at 1,354 and was up 2 points, or 0.2%, following Friday’s close.  For the year, the index is showing a gain of 99 points, or 7.9%.

Last week’s chart for the S&P 500:

The Nasdaq rocketed 42 points higher, or 1.5%, to end at 2,908.  Tech dropped to 2,919 to start the week which was below the prior Friday’s low of 2,921.  This gave us a good feeling the 2,900 level would be paper thin as support.  Tuesday’s fall to 2,891 and the break of the 50-day MA was confirmation a test to 2,850 would be coming.  The Nasdaq traded to a low of 2,866 on Wednesday and closed at 2,887.  Thursday’s low was 2,837 but the index was able to close above 2,850 after settling at 2,866 and was a good clue Friday’s rally and a test back to 2,900 was coming.  Short-term resistance is at 2925-2,950 and a break above 3,000 would be bullish.  The Nasdaq came into Monday’s session at 2,937 and was actually down 29 points, or 1% for the week.  YTD, the Nasdaq is higher by 303 points, or 11.6%.

Here is last week’s chart for Tech:

The Russell 2000 added 11 points, or 1.4%, to close at 800.99.  The small-caps kissed a low of 801 to start the week which was just above short-term support at 800 and the 100-day MA.  The bears pushed 792 during Tuesday’s session and the close of 795 was a warning sign 780 would come back into play.  Thursday’s low was 778 but the index was able to make back much of the session’s losses before the close to finish at 789.  Resistance this week will be 810 and then 820.  If the bears can push 780 again this week, the 200-day MA is likely to fall with a grizzly test to 750.  The Russell 2000 was at 807 coming into the week and was also red, losing 6 points, or 0.7%, for the week.  The index is up 60 points for the year, or 8.1%.

Here is last week’s chart for the Russell 2000 and our mid-August 750 price target:

The S&P Volatility Index ($VIX, 16.74, down 1.59) fell 9% on Friday after starting the week at 17.10.  Thursday’s high on the VIX was 19.51 and we were looking for a finish north of 20 after the close above 17.50 on Monday.  We said last week the VIX could fall to 15 on a continued rally but that traders could get caught off guard as there would be a huge spike back above 20 on a selloff.  Almost.  A test back to resistance and new highs will get the VIX near 15 but everything has to play out perfectly for the bulls to have a continued rally.

Here is the VIX chart from last week:

We really wanted to see a negative close to start the week and Monday’s action was mostly bearish although the bulls did make a push to get things back to even.  The negative prior Friday/ Monday close along with this past Friday’s pullback has given the bears 3-straight red Friday/ Monday’s.  

If you recall, the market spiked 2% on Europe’s plan to come up with a plan to the plan for the plan, well you get the picture and here were our thoughts in a Special Update on 6/29/2012, 9:50am, for our Daily: 

“We know many of you are nervous right now but we are hoping this morning’s opening pop fades.  We have economic news coming out as we type and we expect it to be negative. 

The Dow came to a dead stop just below 12,800 and is up 168 points to 12,770.  The S&P 500 is just under 1,350 with its 20 point pop to 1,349. The Nasdaq is higher by 49 points to 2,898 and is testing 2,900. 

These levels are the next layers of resistance and there are still multiple levels to go before a trend change takes place. 

We will update the market in a couple of hours but remember we have said volatility is picking up and we are going to see huge moves in the indexes over the next week – both ways.  We still believe the trend will be lower next week so let’s see how this plays out.” (END)

In has been just over two weeks since we sent this Special Update and if we would have sent it out just before the market closed on Friday, or right now, it would look fresh.  The 2-month long trading range since the beginning of May appears to be worse than it is because of the huge volatility swings but the fact is just that.  We are still in a range bound market which is great for covered call trading, not so great if playing directional calls and puts.

The events unfolding this week may or may not cause a 3% swing but chances are pretty good they will.  Tech and more Financial earnings will be heavy and will weigh on both the Nasdaq and the Dow.  The earnings bar has been lowered to the dirt for so many companies this quarter that many of them could report “better-than-expected” news.  However, the most important numbers will be the guidance companies give going forward.  If a few high-profile companies can “beat-and-raise” their numbers, stocks could pop.  If not, shares will drop.  Below is a look at some of the possible movers this week.     

Citigroup (C, $25.87, down $0.01) reports their numbers on Monday and Intel (INTC, $25.39, down $0.17) on Tuesday.  American Express (AXP, $57.27, down $0.81), Bank of America (BAC, $7.50, down $0.13), eBay (EBAY, $39.06, down $0.22) and F5 Networks (FFIV, $90.11, down $3.88) announce on Wednesday.  The most important report for the day will be International Business Machines (IBM, $183.56, down $1.69).  Thursday confessions include BB&T (BBT, $30.77, down $0.23), Capital One Financial (COF, $53.50, down $0.54), Chipotle Mexican Grill (CMG, $383.55, up $3.08), Intuitive Surgical (ISRG, $532.35, down $5.09) and Philip Morris International (PM, $90.38, down $0.16).     

July option expiration is Friday and over the past decade, the third Friday in July has been bearish 70% of the time.  In 2002, the Dow lost nearly 5%, falling from 8,409 to 8,109.  In 2010, the blue-chips lost 2.5% after dropping from 10,359 to 10,097.

The Dow closed at 12,777 on Friday.  If we factor in a 3% drop from current levels it would equate to a decline of 400 points.  The Dow made a 200+ point swing intraday last week so a 3% move overall this week is entirely possible.  This would put the blue-chips right at the 12,350 level and at the point of a possible trend change on a move lower.  A 3% move higher would get the Dow to the 13,200 level and at a possible breakout point.

The other wild-card for the week will be Bernanke who will be speaking to the zombies on Tuesday (and again on Wednesday) about the recent FOMC Minutes.  If you recall, Wall Street was a little disappointed following last Wednesday’s Fed statement and if Big Ben mumbles those same thoughts, the market will tank.  If by chance, he hints at some type of QE3 or stimulus plan, the bulls could be running again.

The charts are showing a major move is coming and the earnings cycle will be picking up steam this week.  Add in Friday’s July option expiration and the makings are there for some explosive moves this week.  The 2-month long trading range we have been in could be on the verge of expanding so it will be interesting to see how the week unfolds.

As we head to press, futures are showing a slightly lower open for Monday and look nearly identical to last week’s numbers except for the Nasdaq.  Dow futures are down 25 points to 12,687 while the S&P 500 futures are lower by 3 points to 1,349.  The Nasdaq 100 futures are showing a decline of 6 points to 2,571.      

 

= = = = = = = = = = = = = = = 

 

Key of Technicals Used In Following Articles

2. Antares Pharmaceuticals (ATRS) – Possible Buyout?

By Michael Bryant

 

We have been covering a lot of biotech companies lately, typically because of the huge potential the space offers right now.  We have been mentioning Big Pharmaceutical companies are in need for finding the next blockbuster drugs to replace the revenue lost when their current blockbuster drugs come off patent.  Antares Pharmaceuticals (ATRS, $4.91, up $0.04) could be an attractive candidate with its strong pipeline.

The develops injection devices and topical gel-based products.  It offers Vision/Tjet reusable needle-free injectors that deliver precise medication doses through high-speed pressurized liquid penetration of the skin.  Vibex is a disposable pressure assisted auto injector device that is used for the controlled pressure delivery of drugs into the body utilizing a spring power source.  It also has disposable pen injection systems, which deliver multiple drugs by injection through needles from multi-dose drug cartridges.  Its Advanced Transdermal Delivery (ATD) Gel System penetrates the skin to deliver treatments. 

Anturo is an oxybutynin gel product for the treatment of overactive bladders, and Elestrin is a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms, a sudden opening of the blood vessels close to the skin associated with menopause.  Nestragel is a topical gel delivered by a single dose applied directly to the skin daily for birth control.  

Below is a table for Antares Pharmaceuticals pipeline, partners, and development.

Several of the company’s injectors and drugs had a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) submitted to the FDA.  All but three of its injectors and drugs, highlighted in yellow, have a partner.  The presence of a partner should help the company maintain funding and make it easier to bring the drugs to market.  Five of its products, four injectors and one gel, have already been marketed, mainly in North America and Europe. 

The graph below shows sales are doing well.  Product sales have been steadily increasing but development revenue has surged.  Thus, total revenue has also been rising.  The fact that analysts see a sharp drop in revenue in the next quarter (6/12) could work to boost the stock price, given that analysts will have to raise estimates if they are wrong as it seems highly unlikely that revenue will take a sharp plunge.  Finally, the company could be on the verge of its first profit.  Notice that revenue (blue line) almost touches total expenses (red line).

There is water-cooler talk Pfizer (PFE, $2.81, up $0.14) may make a bid for the company, if it sees blockbuster potential in any of its injectors or drugs.  We have mentioned several times in previous newsletters that Lipitor, Pfizer’s blockbuster cholesterol drug, is coming off patent later this year.  Ranbaxy, an India-based pharmaceutical company, agreed to delay release of its generic version of Lipitor until November 30th.  Lipitor generated $12.7 billion in global sales last year, and $7 billion of that came from the United States.  Thus, a few billion dollar buyout would not sound unreasonable.  Pfizer currently has about $24 billion in its coffers. 

Antares Pharmaceuticals’ injector is one of the few such devices that can easily deliver medication just beneath the surface of the skin.  It has been found that intradermal delivery of certain substances and vaccines are more effective than when they are delivered below the skin.  This could be a huge selling product with possible billions of dollars in sales down the road. 

A buyout from Teva Pharmaceutical Industries (TEVE, $40.38, up 0.31) also makes sense, especially considering it has five partnerships with the Israeli generic drug maker.  Copaxone, Teva’s flagship drug, is a disease-modifying medication for the treatment of multiple sclerosis (MS).  It is administered once-a-day by injection just beneath the skin which makes the company’s injector crucial to Teva’s success for the drug.

At $4.91, the stock is close to its high target of $5.00 made by the 2 analysts recorded by Thomson/First Call.  Median target is $4.50, mean target also is $4.50, and low target is $4.00.  Using a scale of 1.0 as a strong buy and 5.0 as a sell, the average rating of the stock was 1.0, up from 1.5 a week ago. 

 

Current Month

Last Month

Two Months Ago

Three Months Ago

Strong Buy

3

3

2

2

Buy

0

0

0

0

Hold

1

1

1

1

Underperform

0

0

0

0

Sell

0

0

0

0

We like the company which is why we made it an official “Buy” recommendation on Friday.  

 

= = = = = = = = = = = = = = = 

 

3.  Homeowners Choice (HCII) – A Closer Look at the Recent IPO

Homeowners Choice (HCII, $18.31, up $0.65) made a great run since its Initial Public Office (IPO) but can its run continue?

The company provides property and casualty insurance in Florida.  Since 2007, it’s completed nine assumption transactions acquiring 125,000 policies that provided it with $235 million in recurring revenue.  Despite all these transactions, it possesses just a 2.8% market share in Florida.

They keep marketing costs low by assuming insurance policies held by state-supported insurer Citizens Property Insurance.  It transfers substantial portions of its liability and premium to reinsurers and the state-sponsored Florida Hurricane Catastrophic Fund.  Private reinsurers include Amlin AG, Aeolus Reinsurance, Renaissance Reinsurance, Montpelier Reinsurance, various divisions of Lloyd’s Banking Group PLC, and National Liability & Fire Insurance Company, a subsidiary of Berkshire Hathaway. 

Homeowners Choice estimates the probable maximum loss of a 1 in 100 year catastrophic event and then purchases protection that exceeds that loss.  In the current year, its reinsurance programs provide coverage for up to $549 million at a total cost of approximately $92 million.  Under the contracts, it retains approximately $9 million of risk in any one event.

The biggest risk to the stock is hurricanes, tornadoes, and flood damage and would $549 million be enough to cover a catastrophe?  Hurricane Andrew cost the state $26.5 billion in 1992 and 2.8% of that is $742 million.  Thus, the company would record about a $200 million loss if a storm like Hurricane Andrew hit Florida but the chances of that happening look slim for now.

Hurricane season officially began on June 1st and does not end until on November 30th.  Tropical Storm Risk (TSR), a group of experts on insurance, risk management, and seasonal climate forecasting at the University College of London forecast 14 tropical storms this year, 7 of which could form into hurricanes with 3 of those being major hurricanes.  Weather Services International (WSI) also predicted 7 hurricanes with 3 of those being major hurricanes, but forecasted only a total of 12 tropical storms due to a cooler North Atlantic Oscillation combined with weakening La Niña.  The WSI also predicted a slightly elevated chance of a hurricane landfall on the Gulf Coast and a slightly reduced chance along the East Coast.  However, Colorado State University (CSU) stated on April 4th that they expect a below-normal hurricane season. 

 

Tropical Storms

Hurricanes

Major Hurricanes

Tropical Storm Risk

14

7

3

Weather Services International

12

7

3

Colorado State University

10

4

2

The National Oceanic and Atmospheric Administration (NOAA) are predicting a 9-15 tropical storms, 4-8 of which could form hurricanes with 1-3 of those being major hurricanes of Category 3 strength or higher.  Further, Dr. Klotzbach and his team at Colorado State University stated that the chance of a major hurricane hitting the Florida peninsula and the U.S. East Coast is 28%, compared to an average of 31% over the past 100 years.

We compared Homeowners Choice to its other competitors, including Travelers which is one of the nation’s top property and casualty insurance companies.  As first glance, the company looks underpriced, with positives (green) outnumbering negatives (red) 19 to 6.  

 

TCHC = 21st Century Holdings TRV = Travelers UIHC= Unitied Insurance Holdings

UVE = Universal Insurance  Industry = Property & Casualty Insurance

Source:  Numbers calculated from Yahoo Finance and Finviz.com

The most bullish case for the stock is the high margins, the low price/free cash flow, the rising dividend, and the insider buying.  The most bearish case for the stock is the rapidly rising short interest as it has nearly tripled the number of short sellers from the prior month.

The company reported first-quarter revenue came in at $41 million, up from $18 million a year ago.  Earnings came in at $0.88 a share, up $0.13 from a year ago.  For the 2nd quarter, analysts expect $0.59 a share on $36 million, up from $0.30 a share on $19 million in the year ago quarter.  Homeowners Choice not missed estimates for 4 straight quarters. 

At $18.31, the stock is just above its mean target of $18 made by the 3 analysts who follow the company.  Median target is $17.50, high target also is $22.00, and low target is $14.75.  Using a scale of 1.0 as a strong buy and 5.0 as a sell, the average rating of the stock was 1.7, unchanged from a week ago.

 

Current Month

Last Month

Two Months Ago

Three Months Ago

Strong Buy

2

1

2

2

Buy

0

0

0

0

Hold

1

1

0

0

Underperform

0

0

0

0

Sell

0

0

0

0

 

4.  Earnings  

The companies in BOLD, we are looking at as possible trades and we may list call or put options on them in our Daily Newsletter.  If they become official recommendations, we sent out Trade Alerts or include them in our 9am and 1pm updates that come out during the week (Quotes are as of Friday’s close, 7/13/12)

 

Monday

Acacia Research (ACTG, $38.30, up $0.06), Acme United (ACU, $10.48, Flat), Brown & Brown (BRO, $27.19, up $0.04), Cardinal Financial (CFNL, $12.52, up $0.22), Chicopee Bancorp (CBNK, $14.36, up $0.25), CHS (CHSCP, $30.40, down $0.03), Cintas (CTAS, $39.28, up $0.01), Citigroup (C, $25.87, down $0.01), Citizens First (CZFC, $8.85, down $0.13), Citizens Holding (CIZN, $19.28, up $0.25), Codorus Valley Bancorp (CVLY, $13.99, Flat), Community Bank Shares of Indiana (CBIN, $12.52, up $1.03), Consolidated Tomoka Land (CTO, $29.06, UP $0.46), Elmira Savings Bank (ESBK, $19.40, Flat), Enterprise Bancorp (EBTC, $16.75, down $0.19), Equity LifeStyle Properties, (ELS, $68.27, down $0.34), Fidelity Southern (LION, $8.55, down $0.05), First Bancorp, (FNLC, $16.46, down $0.11), First Financial (THFF, $29.83, up $0.32), First M&F (FMFC, $5.69, up $0.24), Gannett, (GCI, $14.29, down $0.25), Hanesbrands (HBI, $29.09, up $0.01), Harleysville Savings Financial (HARL, $17.30, down $0.45), Heartland Express (HTLD, $14.07, down $0.04), Hingham Institution for Savings (HIFS, $59.19, down $0.66), Horizon (HBNC, $25.60, down $0.74), Human Genome Sciences (HGSI, $13.66, up $0.02), ICU Medical (ICUI, $52.41, down $0.11), JB Hunt Transport Services (JBHT, $58.48, down $0.28), Lacrosse Footwear (BOOT, $19.95, up $0.03), Lincare Holdings (LNCR, $41.49, down $0.14), Lincoln Electric Holdings (LECO, $42.26, down $0.20), NB&T Financial (NBTF, $18.23, Flat), Newport Bancorp (NFSB, $13.85, up $0.04), New Hampshire Thrift Bancshares (NHTB, $12.74, up $0.13), NVR (NVR, $847.44, down $7.87), Oak Valley (OVLY, $7.24, Flat), Old Point Financial (OPOF, $10.40, down $0.33), OmegaFlex, (OFLX, $11.14, up $0.03), Orbital Sciences (ORB, $12.83, down $0.11), Packaging Corp. of America (PKG, $28.34, up $0.43), Peoples Financial (PFBX, $10.50, Flat), Pulaski Financial (PULB, $7.32, down $0.05), Rambus (RMBS, $5.13, up $0.06), River Valley (RIVR, $15.64, Flat), Robert Half International (RHI, $28.27, up $0.07), Schiff Nutrition (SHF, $18.31, up $0.11), Sensata Technologies (ST, $26.33, up $0.30), Somerset Hills (SOMH, $8.30, Flat), SVB Financial (SIVB, $56.89, up $0.39), Texas Pacific Land Trust (TPL, $55.90, down $0.17), Tompkins Financial (TMP, $38.59, up $0.24), Travelzoo (TZOO, $21.86, down $0.31), Union First Market Bankshares (UBSH, $15.05, up $0.12), United Continental Holdings, (UAL, $24.79, up $0.93), Weis Markets (WMK, $45.28, down $0.35), YRC Worldwide (YRCW, $6.93, down $0.05)

 

Tuesday

AAR (AIR, $13.37, down $0.11), Albemarle Corporation (ALB, $57.30, down $1.58), Alliance Financial (ALNC, $35.30, down $0.05), BancFirst (BANF, $42.55, up $0.42), Cathay General (CATY, $16.51, up $0.29), Coca-Cola (KO, $77.46, down $0.52), Comerica (CMA, $30.32, up $0.32), CSX (CSX, $22.25, up $0.03), Fidelity National Information Services, (FIS, $34.12, up $0.23), Forest Laboratories (FRX, $35.31, down $0.40), Fulton Financial (FULT, $9.87, up $0.05), The Goldman Sachs Group, (GS, $95.13, up $0.88), Hicks (HKAC, $9.82, up $0.04), Host Hotels & Resorts (HST, $15.50, up $0.03), Intel (INTC, $25.39, down $0.17), Interactive Brokers (IBKR, $14.27, up $0.17), Ironwood Pharmaceuticals, (IRWD, $13.48, down $0.04), JAKKS Pacific, (JAKK, $16.22, up $0.03), Johnson & Johnson (JNJ, $67.90, up $0.02), Kansas City Southern (KSU, $68.66, down $0.74), M&T Bank (MTB, $83.68, up $1.05), Marten Transport (MRTN, $19.32, down $0.06), Mattel (MAT, $31.43, down $0.15), MB Financial (MBFI, $21.49, down $0.09), McMoRan Exploration (MMR, $12.43, up $0.36), Mercantile Bank (MBWM, $18.40, up $0.19), Meridian Interstate Bancorp, (EBSB, $15.06, up $0.36), MicroFinancial (MFI, $8.45, down $0.02), Mosaic (MOS, $55.47, up $0.72), New Oriental Education & Technology (EDU, $22.92, down $0.48), Omnicom Group (OMC, $47.57, down $0.04), Pinnacle Financial (PNFP, $18.92, up $0.03), Renasant (RNST, $16.01, up $0.20), Saba Software (SABA, $8.81, down $0.32), State Street (STT, $43.20, up $0.02), TD Ameritrade Holding (AMTD, $16.50, up $0.22), United Rentals (URI, $32.23, down $0.85), Yahoo (YHOO, $15.80, down $0.02)

 

Wednesday

AO Smith (AOS, $47.80, up $0.21), Abbott Laboratories (ABT, $65.00, down $0.18), AMCOL International (ACO, $29.54, down $0.17), American Express (AXP, $57.27, down $0.81), American National Bankshares (AMNB, $22.86, up $0.65), Amphenol (APH, $51.26, down $0.57), Astoria Financial (AF, $9.67, down $0.27), Bank of America (BAC, $7.50, down $0.13), Bank of New York Mellon (BK, $21.02, down $0.29), (BPFH, $8.72, up $0.04), CR Bard (BCR, $105.27, down $1.18), Central Valley Community (CVCY, $7.06, up $0.06), Charles Schwab (SCHW, $12.30, down $0.27), Check Point Software Technologies (CHKP, $44.24, down $0.95), Cohen & Steers (CNS, $35.01, down $0.39), Community Trust Bancorp (CTBI, $33.90, down $0.03), Core Laboratories (CLB, $110.90, down $2.68), Covanta Holding (CVA, $17.10, down $0.11), Crown Holdings (CCK, $33.28, down $0.31), CVB Financial (CVBF, $11.50, down $0.03), Daxor (DXR, $9.00, down $0.23), Dover (DOV, $50.89, down $0.17), East West Bancorp, (EWBC, $23.18, down $0.09), eBay (EBAY, $39.06, down $0.22), Exponent (EXPO, $52.45, down $0.71), F5 Networks (FFIV, $90.11, down $3.88), First Cash Financial Services (FCFS, $39.97, down $0.39), First Republic Bank (FRC, $32.81, down $0.03), Greenhill (GHL, $33.95, down $0.35), HNI (HNI, $25.70, down $0.31), Honeywell International (HON, $53.32, down $0.38), International Business Machines (IBM, $183.56, down $1.69), Kinder Morgan Energy Partners (KMP, $83.30, down $0.04), Kinder Morgan Management (KMR, $78.70, up $0.10), Knight Capital (KCG, $11.65, down $0.20), LaSalle Hotel Properties (LHO, $28.20, down $0.39), LCNB (LCNB, $13.25, Flat), Mellanox Technologies (MLNX, $64.94, down $4.29), Meta Financial (CASH, $21.04, up $0.14), Navios Maritime Partners (NMM, $12.99, down $0.23), Noble (NE, $33.25, down $0.09), Northern Trust (NTRS, $46.04, up $0.51), NVE (NVEC, $51.41, down $1.23), Pacific Continental (PCBK, $9.23, up $0.02), PacWest Bancorp (PACW, $24.81, up $0.20), Parametric Sound (PAMT, $9.25, down $0.01), Platinum Underwriters (PTP, $38.09, up $0.25), Plexus (PLXS, $26.99, down $0.88), PNC Financial Services (PNC, $60.26, down $1.15), Popular, (BPOP, $15.46, down $0.04), Qualcomm (QCOM, $53.52, down $1.35), RLI (RLI, $69.17, down $0.26), Rocky Brands (RCKY, $13.31, up $0.16), Select Comfort (SCSS, $21.95, up $0.27), Skyworks Solutions (SWKS, $25.92, down $0.24), SLM (SLM, $15.97, down $0.08), SLM (SLM, $15.96, down $0.09), St. Jude Medical (STJ, $38.16, down $0.45), Stanley Black & Decker, (SWK, $58.94, down $0.58), Stryker (SYK, $52.49, down $0.57), Taylor Capital Group (TAYC, $15.96, up $0.12), U.S. Bancorp (USB, $32.06, down $0.22), Umpqua Holdings (UMPQ, $13.21, down $0.11), Union Bankshares (UNB, $19.11, up $0.11), Winmark (WINA, $59.37, up $1.72), Wintrust Financial (WTFC, $34.65, down $0.37), WNS (WNS, $10.00, up $0.06), Xilinx (XLNX, $30.98, down $1.16), Yum Brands (YUM, $62.78, up $0.83)

 

Thursday

Acacia Research (ACTG, $37.96, down $0.46), Align Technology (ALGN, $31.49, down $1.95), Alliance Data Systems (ADS, $131.48, down $2.86), AMCON Distributing (DIT, $61.80, up $2.80), Arbitron (ARB, $33.98, down $0.58), Associated Banc-Corp (ASBC, $12.75, down $0.13), athenahealth (ATHN, $80.75, down $1.45), AutoNation (AN, $39.42, up $0.17), B&G Foods (BGS, $26.19, Flat), Bank of Kentucky Financial (BKYF, $24.53, down $0.10), Baxter International (BAX, $53.80, down $0.17), BB&T (BBT, $30.77, down $0.23), Blackstone (BX, $12.65, down $0.10), Capital One Financial (COF, $53.50, down $0.54), Cass Information Systems (CASS, $39.75, down $0.71), Cepheid (CPHD, $41.96, down $0.19), Chipotle Mexican Grill (CMG, $383.55, up $3.08), City National (CYN, $48.26, down $0.35), CoBiz Financial (COBZ, $6.43, down $0.12), Columbus McKinnon (CMCO, $14.19, down $0.08), Cubist Pharmaceuticals (CBST, $39.91, up $0.92), Cypress Semiconductor (CY, $12.11, down $0.20), Cytec Industries (CYT, $58.53, down $0.48), Danaher (DHR, $49.72, down $0.58), Diamond Offshore Drilling, (DO, $61.16, down $0.01), E*TRADE Financial (ETFC, $7.43, down $0.18), EastGroup Properties (EGP, $52.92, up $0.15), Electronics for Imaging, (EFII, $15.36, down $0.16), Entegris, (ENTG, $8.03, down $0.18), ESB Financial (ESBF, $13.50, up $0.25), Fairchild Semiconductor International (FCS, $13.03, down $0.32), Farmers Capital Bank (FFKT, $6.53, up $0.02), Fifth Third (FITB, $13.29, up $0.13), First Financial Bankshares (FFIN, $35.55, up $0.32), Forward Air (FWRD, $31.88, up $0.13), Freeport-McMoRan Copper & Gold (FCX, $31.80, down $0.56), Freescale Semiconductor Holdings (FSL, $8.73, down $0.16), Gardner Denver (GDI, $50.39, down $0.18), GATX (GMT, $37.64, up $0.31), Genuine Parts (GPC, $59.79, up $0.34), Glimcher Realty (GRT, $10.22, up $0.05), Hanmi Financial (HAFC, $10.64, up $0.16), Home Bancshares, (HOMB, $30.66, down $0.24),  Hub Group (HUBG, $34.38, down $0.38), Huntington Bancshares (HBAN, $6.32, down $0.05), Independent Bank (INDB, $29.60, down $0.05), Insteel Industries (IIIN, $10.03, down $0.42), Intuitive Surgical (ISRG, $532.35, down $5.09), Ixia (XXIA, $12.60, up $0.16), Johnson Controls (JCI, $26.67, down $0.22), KeyCorp (KEY, $7.51, down $0.14), Knoll (KNL, $13.01, down $0.32), Laboratory Corp. of America Holdings (LH, $93.50, up $0.36), Life Time Fitness (LTM, $44.50, DOWN $0.81), Matthews International (MATW, $31.42, down $0.01), Microsoft (MSFT, $28.84, down $0.71), Morgan Stanley (MS, $13.57, down $0.24), Myers Industries (MYE, $16.57, down $0.31), Nash Finch (NAFC, $21.95, down $0.43), National Bankshares (NKSH, $31.25, down $0.30), NCR (NCR, $22.30, down $0.47), NetScout Systems, (NTCT, $20.23, down $1.09), Nucor (NUE, $37.46, down $0.33), OceanFirst Financial (OCFC, $14.02, down $0.11), Orbital Sciences (ORB, $12.95, up $0.12), Overstock.com (OSTK, $6.33, down $0.03), People’s United Financial (PBCT, $11.82, up $0.09), Philip Morris International (PM, $90.38, down $0.16), Pool (POOL, $39.30, down $1.00), PPG Industries (PPG, $100.67, down $0.21), Premiere Global Services, (PGI, $9.41, up $0.05), Quest Diagnostics (DGX, $63.75, up $2.97), Safeway (SWY, $16.05, down $1.93), SanDisk (SNDK, $33.57, down $1.24), Sandy Spring Bancorp (SASR, $18.70, up $0.16), Scholastic (SCHL, $27.54, down $0.38), Sherwin-Williams (SHW, $129.23, up $1.10), Snap-on (SNA, $60.27, up $0.17), Sonoco Products (SON, $29.55, down $0.24), Southwest Airlines (LUV, $9.48, down $0.08), Standard Financial (STND, $16.25, up $0.20), Steel Dynamics (STLD, $11.94, down $0.29), Superior Uniform Group (SGC, $12.68, up $0.03), Swift Transportation (SWFT, $8.27, down $0.21), TCF Financial (TCB, $11.00, down $0.02), Textron (TXT, $22.91, up $0.42), Travelers Companies, (TRV, $62.30, down $0.23), Ultratech, (UTEK, $29.46, up $0.01), Union Pacific (UNP, $116.69, up $0.17), Unitedhealth Group (UNH, $55.02, down $1.02), Universal Forest Products (UFPI, $39.45, up $0.48), Universal Health Realty Income (UHT, $42.88, up $0.22), USA Truck (USAK, $5.00, down $0.31), Verizon Communications (VZ, $44.70, down $0.20), V.F. (VFC, $136.59, up $0.90), Virginia Commerce Bancorp (VCBI, $8.12, down $0.03), Werner Enterprises (WERN, $23.40, up $0.03), WESCO International (WCC, $56.57, up $1.14), Western Alliance (WAL, $9.15, up $0.05), Westwood Holdings Group (WHG, $36.84, down $0.09)

 

Friday

Autoliv, (ALV, $54.03, up $1.08), Badger Meter (BMI, $38.51, down $0.36), Baker Hughes (BHI, $39.30, up $0.45), First Capital (FCAP, $19.07, down $1.93), First Financial Northwest, (FFNW, $8.29, up $0.12), First Horizon National Corporation (FHN, $8.82, up $0.21), First Niagara Financial Group (FNFG, $7.61, up $0.20), General Electric (GE, $19.77, up $0.33), IDEXX Laboratories (IDXX, $92.38, down $1.26), Ingersoll-Rand (IR, $40.96, up $1.32), Main Street Capital (MAIN, $25.06, up $0.68), ManpowerGroup (MAN, $33.91, down $0.01), Meridian Bioscience (VIVO, $19.46, up $0.12), Merit Medical Systems, (MMSI, $14.03, up $0.06), Metrocorp Bancshares (MCBI, $10.84, up $0.38), Monarch Casino & Resort (MCRI, $8.87, up $0.10), Monro Muffler Brake (MNRO, $36.07, up $0.01), SY Bancorp (SYBT, $24.83, up $0.49), Schlumberger (SLB, $66.72, up $1.33), Sensient Technologies (SXT, $36.67, up $0.69), SunTrust Banks (STI, $24.75, up $1.01), Syntel (SYNT, $58.88, up $0.34), United Financial Bancorp, (UBNK, $14.85, up $0.15), Westamerica Bancorp. (WABC, $48.22, up $0.88), Wynn Resorts (WYNN, $96.22, down $0.53), Xerox (XRX, $7.27, down $0.13)

 

= = = = = = = = = = = = = = = 

 

5.  Weekly Wrap Covered Call Portfolio Update (Closing prices as of 7/13/12)

 

Closed Trades for 2012 (20-0, overall):  BAC +26%, EFTC +8%, SZYM +55%, VVUS +38%, CALL +19%, BAC +20%, SYMC +16%, DAR +20%,TIVO +5%, MGM +22%, ZNGA+13%, SGMS +6%, VVUS +17%, F +8%, AA +7%, CLNE +27%, DNDN +18%, MGM +19%, ACAS +3%, P +9%.

 

Antares Pharma (ATRS, $4.91, up $0.04)

August 5 calls (ATRS120818C00005000, $0.50, down $0.05) 

Original Entry Price:  $4.94 (7/13/12)

Lowered Price from Selling Options:  $4.24

Exit Target:  $8+

Return:  16%

Stop Target:  None

Action:  (This was our first trade in 3 months and we see a lot of opportunities in the coming months to add new trades.  We just have to be patient). 

Shares are near 52-week highs but you can see from the 20-year chart (2nd ATRS chart) where shares have been.  The August 5 calls traded up to 75 cents on Friday so everyone should have gotten nice fill prices when the sold them.

We recommended buying the stock at $4.94 on 7/13/2012 and for every 100 shares to sell the August 5 calls for 70 cents.  This lowered the cost basis to $4.24. 

If we are called away in mid-August at $5 the trade will make 18%. 

 

Antares Pharma (ATRS, $4.91, up $0.04)

February 7.50 calls (ATRS130216C0007500, $0.90, up $0.15)

Original Entry Price:  $0.80 (7/13/12)

Exit Target:  $1.60

Return:  13%

Stop Target:  None

Action:  This is a LEAP option which expires in 214 days so we have plenty of time to wait for shares to double.  The calls traded to a high of $1.05 and will be worth at least $2.50 if shares reach $10.  We have to wait it out until mid-February but this would give us a 213% return.       

Solazyme (SZYM, $11.78, up $0.16)

July 12.50 calls (SZYM120721C00012500, $0.20, flat)

Original Entry Price:  $12.40 (4/17/12)

Lowered Price from Selling Options:  $11.30

Exit Target:  $15+

Return:  4%

Stop Target:  None

Action:  Another analyst downgrade early in the week sent shares tumbling.  We highlighted the 50-day and 200-day MA last week and the drop to $11.81 on Monday was bearish.  Shares fell another 8% on Tuesday and below both support levels before finishing back above them on Friday.  Support is at $11 with $10.50 serving as backup while short-term resistance will come in at $12.50 which is just above the 100-day MA. 

We recommended buying the stock at $12.40 on 4/17/2012 and for every 100 shares to sell the June 15 calls for 40 cents.  This lowered the cost basis to $12.00. 

On 6/19/12 we sold the July 12.50 calls for 70 cents which lowered our cost basis to $11.30.  If we are called away in mid-July at $12.50 the trade will make 11%. 

 

Bank of America (BAC, $7.82, up $0.34) 

August 9 calls (BAC120818C00009000, $0.08, down $0.02) 

Original Entry Price:  $8.93 (4/17/12)

Lowered Price from Selling Options and Dividends:  $8.24  

Exit Target:  $15+

Return:  -5%

Stop Target:  None 

Action:  We mentioned the next level of support was at $7.50 and shares closed at $7.48 on Thursday.  This opened the door for a test down to $7 but a rising JP tide lifted all Financial boats on Friday.  Resistance is at $8-$8.25 and a move above the 100-day MA would be bullish.

We recommended buying the stock at $8.93 on 4/17/2012 and for every 100 shares to sell the May 9calls for 45 cents.  This lowered the cost basis to $8.48. 

On 5/30/12 the company paid a 1 cent quarterly dividendwhich lowered our cost basis to $8.47. 

On 6/19/12 we sold the August 9 calls for 23 cents to lower our cost basis to $8.24.  If shares are called away in mid-August at $9 the trade will make 9%. 

 

Scientific Games (SGMS, $8.21, up $0.21)   

Original Entry Price:  $11.10 (3/20/12)

Lowered Price from Selling Options:  Waiting for shares to reach $10-$11

Exit Target:  $15+

Return:  -26%

Stop Target:  None

Action:  Shares traded below $8 on Thursday and Friday and there is further pressure down to $7.xx as you can see from the 2-year chart.  We are still waiting for a move past $9 before we write a call option.  Resistance has been hard to clear but a move above $9 would be bullish.  

We recommended buying the stock at $11.10 on 3/20/2012.

 

Arena Pharmaceuticals (ARNA, $11.18, up $0.57)

July 3 calls (ARNA120723C00003000, $8.15, up $0.55)

Original Entry Price:  $1.88 (2/2/12)

Lowered Price from Selling Options:  $1.33

Exit Target:  $3+

Return:  710%

Stop Target:  None

Action:  We will be called away from Arena on Friday at $3.  The company won approval from the FDA for their obesity drug, Lorcaserin, and we will be looking to establish another position once we are called away in less than 2 weeks.  Shares could be volatile with Vivus (VVUS, $27.16, down $0.07) expected to hear from the FDA this week on their obesity drug, Qnexa.

We recommended buying the stock at $1.88 on 2/2/2012 and for every 100 shares to sell the July 3 calls for 50 cents.  This lowered the cost basis to $1.33. 

If shares are called-away by mid-July at $3 the trade makes 117%. 

 

MGM Resorts (MGM, $9.80, up $0.05)

Original Entry Price:  $13.77 (2/2/12)

Lowered Price from Selling Options:  $12.67

Exit Target:  $15

Return:  -23%

Stop Target:  None

Action:  Shares fell below $10 on Thursday’s action which opened the door for a test down to $9, possibly $7.50.  We would add to the position at $7.50 and buy LEAPs if there is continued weakness.  In 2009, shares fell below $2 but we doubt tjhey get that cheap.  Resistance is now at $10.25 going forward.  We still believe an online gambling bill will pass but it may take another 6-12 months.

We recommended buying the stock at $13.77 on 2/2/2012 and for every 100 shares to sell the March 15 calls for 45 cents.  This lowered the cost basis to $13.32.

On 3/20/12 we recommended selling the April 14 calls for $0.65 which lowered the cost basis to $12.67.

 

Alcoa (AA, $8.42, up $0.12)

August 9 calls (AA120818C00009000, $0.10, flat)

Original Entry Price:  $9.65 (1/12/12)

Lowered Price from Selling Options and Dividends:  $8.76

Exit Target:  $11

Return:  -4%

Stop Target:  None

 Action:  Alcoa reported earnings last week and beat Wall Street’s estimates by a penny after the close on Monday.  The company actually reported a “flat” quarter, or $0.00 a share, but special items lead to a six cent gain and revenues did come in higher than estimates.

Shares fell 4% on Tuesday after opening with a slight gain as the market didn’t buy their outlook.  We knew the close of $8.40 was bearish as the 52-week low of $8.21 was now in play.  Alcoa kissed it on the lips before bouncing but there is still risk down to $7.50.  Resistance at $8.50 was hard to clear all week but a break above should get shares near $9 which is where we could get called away by mid-August.

We recommended buying the stock at $9.65 on 1/12/12. 

On 1/23/12 we recommended selling the March 11 calls for $0.25 which lowered the cost basis to $9.40. 

On 2/1/12 the company paid a 3 cent dividend which lowered our cost basis to $9.37. 

On 3/20/12 we recommended selling the April 11 calls for $0.20 which lowered the cost basis to $9.17. 

On 5/10/12 the company paid a 3 cent quarterly dividendwhich lowered our cost basis to $9.14. 

On 6/19/12 we sold the August 9 calls for 38 cents to lower our cost basis to $8.76.  If shares are called away in mid-August at $9 the trade will make 3%.

 

Trades on HOLD:  DryShips (DRYS, $2.20, up $0.06), AKS Steel Holding (AKS, $5.60, down $0.12), Rare Element Resources (REE, $4.79, up $0.23), NewparkResources (NR, $6.23, up $0.39), Rambus (RMBS, $5.16, down $0.10), Patriot Coal (PCXCQ, $0.27, down $0.02), OCZ Technology Group (OCZ, $6.31, up $0.14), Pizza Inn (PZZI, $2.47, down $0.02), Bebe Stores (BEBE, $5.98, down $0.01)

 Special Alert:  Patriot Coal (PCXCQ, $0.27, down $0.02) has filed for Chapter 11 bankruptcy which makes holding shares a no win situation. 

We were hoping the stock would make a comeback and knew something was up when shares popped from $1.22 to $2.26 the prior week.  We also thought there was a chance Patriot Coal would receive a buyout offer but the coal industry is a mess.  China is still importing it by the boatloads but the industry is in a free fall. 

Last Monday’s announcement ruined any chance for a comeback so we will see how things go and if they wipe out the common stock.  We only has a small position in the stock and we never really bought the dips or added to the position because shares have been in a steady downfall for over a year now. 

 

= = = = = = = = = = = = = = = 

 

6.  Week Ahead

 

This will be a busy week for economic reports and it is also July option expiration on Friday.

 

Monday headlines will start with the Retail Sales and Empire Manufacturing numbers at 8:30am (EST) followed by Business Inventories at 10am.  All 3 reports should sway market direction.

 

For Tuesday, the Consumer Price Index (CPI) report should move futures at 8:30am as it is an important reading on inflation.  With corn crops struggling, higher food prices are on the way and this should be reflected in the numbers.  At 9am, Net Long-Term TIC Flows will be released at 9am with Industrial Production and Capacity Utilization coming 15 minutes later.  At 10am, the NAHB Housing Market Index is due out.

 

The MBA Mortgage Index kicks off Wednesday’s action at 7am with Housing Starts and Building Permits scheduled at 8:30am.  At 10:30am, the weekly Crude Inventories will be updated and at 2pm, the Fed’s Beige Book will be released.  

 

Thursday’s Initial and Continuing Claims will be an important read at 8:30.  Existing Home Sales numbers will hit Wall Street at 10am along with the Philly Fed and Leading Indicators.

 

There are no scheduled economic reports for Friday.

 

 

 

Scroll to Top